ACADL Antikörper (AA 31-130) (Cy5.5)
Kurzübersicht für ACADL Antikörper (AA 31-130) (Cy5.5) (ABIN1406531)
Target
Alle ACADL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-130
-
Homologie
- Human,Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ACADL
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- ACADL (Acyl-CoA Dehydrogenase, Long Chain (ACADL))
-
Andere Bezeichnung
- ACADL
-
Hintergrund
-
Synonyms: mitochondrial, ACAD4, ACADL, ACADL_HUMAN, Acyl Coenzyme A dehydrogenase long chain, FLJ94052, LCAD, Long chain acyl CoA dehydrogenase, Long-chain specic acyl-CoA dehydrogenase.
Background: The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family, which is a family of mitochondrial flavoenzymes involved in fatty acid and branched chain amino-acid metabolism. This protein is one of the four enzymes that catalyze the initial step of mitochondrial beta-oxidation of straight-chain fatty acid. Defects in this gene are the cause of long-chain acyl-CoA dehydrogenase (LCAD) deficiency, leading to nonketotic hypoglycemia. [provided by RefSeq].
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-